Hyptolide Promotes Breast Cancer Stem Cells Apoptosis and S-phase Cell Cycle Arrest
Taken together, hyptolide has potential for treating BCSCs by targeting SRC, EGFR, and MAPK1 signaling. Further investigation of the molecular mechanisms involved is required to develop hyptolide as a BCSC-targeted drug.
Authors
- Meiny Suzery (ORCID: https://orcid.org/0000-0002-1163-4186)
- Bambang Cahyono (ORCID: https://orcid.org/0000-0002-9800-6683)
- Nur Dina Amalina (ORCID: https://orcid.org/0000-0002-6314-3661)
Institutions
- Diponegoro University (ID)
- State University of Semarang (ID)
Publication Details
- Journal
- Asian Pacific Journal of Cancer Prevention
- Published
- 2025-09-01
- DOI
- https://doi.org/10.31557/apjcp.2025.26.9.3203
- Primary Topic
- Phytochemical compounds biological activities
- Type
- article
- Field-Weighted Citation Impact
- 0.00